Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-019674

Chief Executive Officer acquired 95,763 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Santos da Silva Jorge · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-27 Grant or award : show line 1 in the form +95,763 3,078,577 D
Loading xslF345X05/ownership.xml…